Founded in 2002, Quaker BioVentures is based in Philadelphia and focuses on investing in healthcare companies in North America. They typically invest in rounds with 5-6 participants and have partnered with other firms such as Domain Associates and Investor Growth Capital Limited. Some of their notable portfolio companies include Celator Pharmaceuticals, Rapid Micro Biosystems, and TetraLogic Pharmaceuticals. With over $700 million in committed capital, Quaker BioVentures manages funds that lead equity investments in healthcare companies at all stages of development, specializing in pharmaceuticals, biotechnology, healthcare services, and medical technologies.